{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:59:36Z","timestamp":1792519176320,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005672","name":"FUNDECT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bioorg.2021.105485","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T21:21:40Z","timestamp":1637356900000},"page":"105485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Anti-inflammatory, ulcerogenic and platelet activation evaluation of novel 1,4-diaryl-1,2,3-triazole neolignan-celecoxib hybrids"],"prefix":"10.1016","volume":"119","author":[{"given":"Josyelen L.","family":"Felipe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana B.","family":"Cassamale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia D.","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego B.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarith R.","family":"das Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C.F.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica C.","family":"Toffoli-Kadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano C.M.","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105485_b0005","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2174\/092986710790979980","article-title":"Progress in COX-2 inhibitors: a journey so far","volume":"17","author":"Chakraborti","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1590\/S0066-782X2010000400019","article-title":"Nonsteroidal anti-inflammatory drugs: cardiovascular, cerebrovascular and renal effects","volume":"94","author":"Batlouni","year":"2010","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.bioorg.2021.105485_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/536962","article-title":"NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species","volume":"2015","author":"Ghosh","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bioorg.2021.105485_b0020","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/art.21132","article-title":"Selective cyclooxygenase 2 inhibitors and cardiovascular events","volume":"52","author":"Solomon","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bioorg.2021.105485_b0025","first-page":"125","article-title":"The coxibs and traditional nonsteroidal anti-inflammatory drugs: A current perspective on cardiovascular risks","volume":"23","author":"Cairns","year":"2007","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.bioorg.2021.105485_b0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jcpt.12484","article-title":"Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis","volume":"42","author":"Gunter","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bioorg.2021.105485_b0035","series-title":"Inflammation in the Pathogenesis of Chronic Diseases","author":"Mason","year":"2008"},{"key":"10.1016\/j.bioorg.2021.105485_b0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1440-1746.2011.07036.x","article-title":"Severe acute liver injury associated with lumiracoxib","volume":"27","author":"Pillans","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2021.105485_b0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FJC.0b013e318157f72d","article-title":"COX-2 Inhibitors and Cardiovascular Risk : Journal of Cardiovascular Pharmacology","volume":"50","author":"Funk","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105485_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117631","article-title":"Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: A review","volume":"251","author":"Arora","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2021.105485_b0055","first-page":"179","article-title":"Butterfly structure: a scaffold of therapeutic importance, Future","volume":"12","author":"Choudhary","year":"2020","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0060","first-page":"1288","article-title":"Design, Synthesis and Biological Evaluation of New Imidazo[2,1-b]Thiazole Derivatives as Selective COX-2 Inhibitors","volume":"17","author":"Shahrasbi","year":"2018","journal-title":"Iran. J. Pharm. Res. IJPR."},{"key":"10.1016\/j.bioorg.2021.105485_b0065","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1073\/pnas.0601805103","article-title":"Partnering between monomers of cyclooxygenase-2 homodimers","volume":"103","author":"Yuan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2021.105485_b0070","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0223-5234(03)00115-6","article-title":"Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs","volume":"38","author":"Charlier","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0080","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1016\/j.bmc.2015.06.008","article-title":"Structure Based Library Design (SBLD) for new 1,4-dihydropyrimidine scaffold as simultaneous COX-1\/COX-2 and 5-LOX inhibitors","volume":"23","author":"Lokwani","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0085","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/med.21424","article-title":"Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety","volume":"37","author":"Pereira-Leite","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2021.105485_b0090","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1016\/j.tetlet.2010.10.136","article-title":"An asymmetric route to total synthesis of the furano lignan (+)-veraguensin","volume":"51","author":"Matcha","year":"2010","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2021.105485_b0095","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-2000-9564","article-title":"Tetrahydrofuran lignans from Illicium floridanum and their activity in a luminol enhanced chemiluminescence assay","volume":"66","author":"Schmidt","year":"2000","journal-title":"Planta Med."},{"key":"10.1016\/j.bioorg.2021.105485_b0100","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1021\/np050283e","article-title":"Bioactive tetrahydrofuran lignans from Peperomia dindygulensis","volume":"68","author":"Wu","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2021.105485_b0105","doi-asserted-by":"crossref","unstructured":"A.A. da Silva Filho, M.L. Andrade e Silva, J.C.T. Carvalho, J.K. Bastos, Evaluation of analgesic and anti-inflammatory activities of Nectandra megapotamica (Lauraceae) in mice and rats, J. Pharm. Pharmacol. 56 (2004) 1179\u20131184. DOI: 10.1211\/0022357044058.","DOI":"10.1211\/0022357044058"},{"key":"10.1016\/j.bioorg.2021.105485_b0110","first-page":"1217","article-title":"Synthesis and antitrypanosomastid activity of 1, 4-diaryl-1, 2, 3-triazole analogues of neolignans veraguensin, grandisin and machilin G","volume":"27","author":"Cassamale","year":"2016","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105485_b0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/cbdd.13417","article-title":"Design, synthesis and antitrypanosomatid activities of 3, 5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G","volume":"93","author":"Trefzger","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2021.105485_b0120","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/molecules21060802","article-title":"Antileishmanial Activity and Structure-Activity Relationship of Triazolic Compounds Derived from the Neolignans Grandisin","volume":"21","author":"Costa","year":"2016","journal-title":"Veraguensin, and Machilin G, Molecules."},{"key":"10.1016\/j.bioorg.2021.105485_b0125","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1111\/cbdd.13609","article-title":"Effect of isoxazole derivatives of tetrahydrofuran neolignans on intracellular amastigotes of Leishmania (Leishmania ) amazonensis : A structure\u2013activity relationship comparative study with triazole-neolignan-based compounds","volume":"94","author":"Neves","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2021.105485_b0130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/np970445+","article-title":"Magnone A and B, Novel Anti-PAF Tetrahydrofuran Lignans from the Flower Buds of Magnolia fargesii | Journal of Natural Products","volume":"61","author":"Jung","year":"1988","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2021.105485_b0135","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0223-5234(91)90200-7","article-title":"Synthetic butanolide and tetrahydrofuran lignans with platelet activating factor antagonist activity","volume":"26","author":"Coran","year":"1991","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0140","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/jm00160a020","article-title":"Conformation and activity of tetrahydrofuran lignans and analogs as specific platelet-activating-factor antagonists | Journal of Medicinal Chemistry","volume":"29","author":"Biftu","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1755-5922.12233","article-title":"Platelet activating factor: A potential biomarker in acute coronary syndrome?","volume":"35","author":"Palur Ramakrishnan","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.bioorg.2021.105485_b0150","first-page":"4414","article-title":"Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical","volume":"24","author":"Lordan","year":"2019","journal-title":"Current, and Future Research Perspectives, Molecules."},{"key":"10.1016\/j.bioorg.2021.105485_b0155","series-title":"The Practice of Medicinal Chemistry - 3rd Edition","author":"Wermuth","year":"2008"},{"key":"10.1016\/j.bioorg.2021.105485_b0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: Current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorganic Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0165","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.bioorg.2021.105485_b0170","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.tetlet.2015.03.136","article-title":"New click-chemistry methods for 1,2,3-triazoles synthesis: recent advances and applications","volume":"56","author":"Totobenazara","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2021.105485_b0175","series-title":"Purification of laboratory chemicals","author":"Armarego","year":"2017"},{"key":"10.1016\/j.bioorg.2021.105485_b0180","first-page":"109","article-title":"Design, Synthesis and Anticancer Biological Evaluation of Novel 1,4-Diaryl-1,2,3-triazole Retinoid Analogues of Tamibarotene (AM80)","volume":"29","author":"Aleixo","year":"2018","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105485_b0185","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N."},{"key":"10.1016\/j.bioorg.2021.105485_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01966691","article-title":"Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity","volume":"17","author":"de Souza","year":"1985","journal-title":"Agents Actions."},{"key":"10.1016\/j.bioorg.2021.105485_b0195","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.2042-7158.1978.tb13214.x","article-title":"Inhibitors of gastric lesions in the rat","volume":"30","author":"Hayden","year":"1978","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105485_b0200","first-page":"329","article-title":"Antiulcerogenic activity of crude extract, fractions and populnoic acid isolated from Austroplenckia populnea (Celastraceae), Z. Naturforschung C","volume":"61","author":"Andrade","year":"2006","journal-title":"J. Biosci."},{"key":"10.1016\/j.bioorg.2021.105485_b0205","first-page":"172","article-title":"Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry","volume":"18","author":"Tomer","year":"2004","journal-title":"J. Biol. Regul. Homeost. Agents."},{"key":"10.1016\/j.bioorg.2021.105485_b0210","doi-asserted-by":"crossref","unstructured":"L.G. Freitas, R. Sathler-Avelar, D.M. Vitelli-Avelar, S.R. Bela, A. Teixeira-Carvalho, M. Das Gra\u00e7as Carvalho, L.M.S. Dusse, Preeclampsia: integrated network model of platelet biomarkers interaction as a tool to evaluate the hemostatic\/immunological interface, Clin. Chim. Acta. 436 (2014) 193\u2013201. DOI: 10.1016\/j.cca.2014.05.020.","DOI":"10.1016\/j.cca.2014.05.020"},{"key":"10.1016\/j.bioorg.2021.105485_b0215","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1016\/j.bmcl.2010.07.054","article-title":"The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life","volume":"20","author":"Wang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105485_b0220","doi-asserted-by":"crossref","unstructured":"G. Bitencourt-Ferreira, W.F. de Azevedo, Molegro Virtual Docker for Docking, in: W.F. de Azevedo Jr. (Ed.), Docking Screens Drug Discov., Springer, New York, NY, 2019: pp. 149\u2013167. DOI: 10.1007\/978-1-4939-9752-7_10.","DOI":"10.1007\/978-1-4939-9752-7_10"},{"key":"10.1016\/j.bioorg.2021.105485_b0225","series-title":"Spartan 16","author":"Henre","year":"2017"},{"key":"10.1016\/j.bioorg.2021.105485_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules | Scientific Reports","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2021.105485_b0235","year":"2020","journal-title":"Biovia, San Diego"},{"key":"10.1016\/j.bioorg.2021.105485_b0240","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1016\/j.tetlet.2006.05.079","article-title":"A new solvent system for efficient synthesis of 1,2,3-triazoles","volume":"47","author":"Lee","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2021.105485_b0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bioorg.2021.105485_b0250","series-title":"Book Review: ADME and Translational Pharmacokinetics\/Pharmacodynamics of Therapeutic Proteins - Agoram - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library","author":"Agoram","year":"2017"},{"key":"10.1016\/j.bioorg.2021.105485_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112918","article-title":"Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety","volume":"209","author":"Sa\u011fl\u0131k","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103540","article-title":"New pyrazole derivatives possessing amino\/methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies","volume":"95","author":"Abdellatif","year":"2020","journal-title":"Bioorganic Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130554","article-title":"Design, synthesis of new anti-inflammatory agents with a pyrazole core: COX-1\/COX-2 inhibition assays, anti-inflammatory, ulcerogenic, histopathological, molecular Modeling, and ADME studies","volume":"1240","author":"Abdellatif","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2021.105485_b0270","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1021\/jm2001376","article-title":"Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase","volume":"54","author":"Hwang","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0275","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/1381612043453108","article-title":"Clinical Pharmacology of Novel Selective COX-2 Inhibitors","volume":"10","author":"Tacconelli","year":"2004","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.bioorg.2021.105485_b0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.1711040103","article-title":"Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine","volume":"104","author":"Rosa","year":"1971","journal-title":"J. Pathol."},{"key":"10.1016\/j.bioorg.2021.105485_b0285","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejmech.2018.11.027","article-title":"Anti-inflammatory activity of triazine derivatives: A systematic review","volume":"162","author":"Mar\u00edn-Ocampo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0290","first-page":"2962","article-title":"Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects","volume":"159","author":"Beck","year":"1997","journal-title":"J. Immunol. Baltim. Md."},{"key":"10.1016\/j.bioorg.2021.105485_b0295","first-page":"222","article-title":"The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo","volume":"73","author":"Faccioli","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.bioorg.2021.105485_b0300","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1523-1747.ep12481893","article-title":"Prostaglandiins and chemotaxis: enhancement of polymorhonuclear leukocyte chemotaxis by prostaglandin f 2 \u03b1","volume":"66","author":"Diaz-Perez","year":"1976","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioorg.2021.105485_b0305","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0002-9440(10)61701-4","article-title":"PGF2\u03b1, a Prostanoid Released by Endothelial Cells Activated by Hypoxia, Is a Chemoattractant Candidate for Neutrophil Recruitment","volume":"159","author":"Arnould","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bioorg.2021.105485_b0310","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ptr.2882","article-title":"Antinociceptive and antiinflammatory activities of grandisin extracted from Virola surinamensis","volume":"24","author":"Carvalho","year":"2009","journal-title":"Phytotherapy Res."},{"key":"10.1016\/j.bioorg.2021.105485_b0315","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bcp.2008.07.009","article-title":"Celecoxib inhibits 5-lipoxygenase","volume":"76","author":"Maier","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105485_b0320","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0035-2016","article-title":"Lipid Mediators in Inflammation","volume":"4","author":"Bennett","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bioorg.2021.105485_b0325","first-page":"1005","article-title":"Peptic Ulcer Disease","volume":"76","author":"Ramakrishnan","year":"2007","journal-title":"Am. Fam. Physician."},{"key":"10.1016\/j.bioorg.2021.105485_b0330","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","article-title":"Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs","volume":"154","author":"Bjarnason","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.bioorg.2021.105485_b0335","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","article-title":"Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn\u2019t the Stomach Digest Itself? Physiological Reviews","volume":"88","author":"Wallace","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bioorg.2021.105485_b0340","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1021\/jf0628835","article-title":"Caffedymine from Cocoa Has COX Inhibitory Activity Suppressing the Expression of a Platelet Activation Marker, P-Selectin","volume":"55","author":"Park","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2021.105485_b0345","doi-asserted-by":"crossref","unstructured":"M. Reyes Gil, Chapter 91 - Overview of the Coagulation System, in: B.H. Shaz, C.D. Hillyer, M. Reyes Gil (Eds.), Transfus. Med. Hemost. Third Ed., Elsevier, 2019: pp. 559\u2013564. DOI: 10.1016\/B978-0-12-813726-0.00091-X.","DOI":"10.1016\/B978-0-12-813726-0.00091-X"},{"key":"10.1016\/j.bioorg.2021.105485_b0350","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/14728222.11.8.1103","article-title":"P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis","volume":"11","author":"Ludwig","year":"2007","journal-title":"Expert Opin. Ther. Targets."},{"key":"10.1016\/j.bioorg.2021.105485_b0355","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","article-title":"The adhesion molecule P-selectin and cardiovascular disease","volume":"24","author":"Blann","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioorg.2021.105485_b0360","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jacc.2006.08.009","article-title":"Platelet function assessment to predict outcomes after coronary interventions: hype or hope?","volume":"48","author":"Alfonso","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bioorg.2021.105485_b0365","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0092-8674(93)80055-J","article-title":"Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice","volume":"74","author":"Mayadas","year":"1993","journal-title":"Cell."},{"key":"10.1016\/j.bioorg.2021.105485_b0370","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.jacc.2013.03.004","article-title":"Targeting p-selectin during coronary interventions: the elusive link between inflammation and platelets to prevent myocardial damage","volume":"61","author":"Alfonso","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bioorg.2021.105485_b0375","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.2147\/IJN.S316863","article-title":"Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models","volume":"16","author":"Feng","year":"2021","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.bioorg.2021.105485_b0380","doi-asserted-by":"crossref","first-page":"268","DOI":"10.18632\/oncotarget.19374","article-title":"Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent","volume":"9","author":"Zhu","year":"2018","journal-title":"Oncotarget"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:29:56Z","timestamp":1758616196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821008634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":76,"alternative-id":["S0045206821008634"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105485","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory, ulcerogenic and platelet activation evaluation of novel 1,4-diaryl-1,2,3-triazole neolignan-celecoxib hybrids","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105485"}}